SBOM Vulnerability Management for Medical Devices Guide

Master SBOM vulnerability management for medical devices. Learn to track, triage, and mitigate software risks to meet FDA premarket and postmarket requirements.

This guide is written for medical device manufacturers navigating SBOM vulnerability management medical devices. It is built from real submissions, FDA correspondence, and the standards reviewers actually cite. Use it as a working reference: read straight through, jump to the section that matches your current gap, or hand it to your engineering and regulatory leads as a checklist.

The Intersection of SBOM and Vulnerability Management

The Intersection of SBOM and Vulnerability Management is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Defining SBOM in the MedTech Lifecycle

Defining SBOM in the MedTech Lifecycle. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Why SBOMs are Essential for Vulnerability Monitoring

Why SBOMs are Essential for Vulnerability Monitoring. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

FDA Requirements for SBOM and Vulnerability Disclosure

FDA Requirements for SBOM and Vulnerability Disclosure is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Section 524B and Postmarket Management

Section 524B and Postmarket Management. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Premarket Expectations for Software Transparency

Premarket Expectations for Software Transparency. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Developing a Vulnerability Triage Workflow

Developing a Vulnerability Triage Workflow is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Matching SBOM Components to Known CVEs

Matching SBOM Components to Known CVEs. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Risk Scoring: CVSS vs. Medical Device Impact

Risk Scoring: CVSS vs. Medical Device Impact. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Identifying False Positives with VEX (Vulnerability Exploitability eXchange)

Identifying False Positives with VEX (Vulnerability Exploitability eXchange). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Postmarket Surveillance: Bridging the Gap from SBOM to Patch

Postmarket Surveillance: Bridging the Gap from SBOM to Patch is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Continuous Monitoring Requirements

Continuous Monitoring Requirements. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Coordinated Vulnerability Disclosure (CVD) Programs

Coordinated Vulnerability Disclosure (CVD) Programs. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Common Pitfalls in MedTech SBOM Management

Common Pitfalls in MedTech SBOM Management is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Transitive Dependency Gaps

Transitive Dependency Gaps. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Static SBOMs in a Dynamic Threat Landscape

Static SBOMs in a Dynamic Threat Landscape. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

How Blue Goat Cyber Automates and Validates SBOM Workflows

How Blue Goat Cyber Automates and Validates SBOM Workflows is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

How Blue Goat Cyber Approaches SBOM vulnerability management medical devices

We treat SBOM vulnerability management medical devices as a regulated engineering workstream, not a one-time document drop. Every engagement is led by senior medical-device security engineers who have shipped 250+ FDA cybersecurity submissions across 510(k), De Novo, PMA, and EU MDR pathways. Here is how we run it end to end:

• Scoping against your device profile. We baseline connectivity, interfaces, data flows, and intended use before we touch a template - because reviewer expectations for a Class II wearable are not the same as a networked hospital platform.
• Standards mapping in writing. Every deliverable is traced to the February 2026 FDA premarket cybersecurity guidance, AAMI SW96, AAMI TIR57 / TIR97, IEC 81001-5-1, and ISO 14971 - with the citation in the artifact itself so reviewers do not have to guess.
• Evidence generated inside your QMS. Threat models, SBOMs, security risk assessments, and test reports are versioned under design controls so the traceability from requirement → test → residual risk holds up under audit.
• Independent testing where it counts. Penetration testing and vulnerability analysis are executed by a testing team that does not also write the design - the separation FDA reviewers increasingly expect on cyber devices.
• Deficiency-ready posture. We anticipate the RTA, AI-letter, and Major deficiency patterns FDA has issued over the past 24 months and pre-empt them in the initial submission, cutting the odds of a second review cycle.
• Postmarket handoff, not abandonment. Every premarket package leaves you with a working postmarket monitoring plan, CVD process, and update cadence so the evidence you shipped stays defensible after clearance.

If you want that treatment applied to your SBOM vulnerability management medical devices package, our FDA Premarket Cybersecurity Services and FDA Cybersecurity Deficiency Response engagements are the two most common entry points.

Frequently asked questions

How do I use an SBOM for medical device vulnerability management?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What are the FDA requirements for SBOM in postmarket surveillance?

Short answer: SBOM vulnerability management medical devices is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How does VEX work with medical device SBOMs?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How often should medical device SBOMs be updated for vulnerabilities?

Short answer: It depends on the device classification, intended use, and connectivity profile. But the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What tools are used for SBOM vulnerability scanning in MedTech?

Short answer: It depends on the device classification, intended use, and connectivity profile. But the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How to handle vulnerabilities in third-party libraries within an SBOM?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Where this fits in the cluster

This page sits downstream of our pillar resources on SBOM vulnerability management medical devices. If you arrived here from a different starting point, these are the most useful adjacent pages:

• FDA-Compliant SBOM Services
• FDA Postmarket Cybersecurity Services
• The Postmarket Cybersecurity Readiness Plan
• Legacy Medical Device Cybersecurity

Related from Blue Goat Cyber

• FDA Premarket Cybersecurity Services
• Medical Device Penetration Testing
• Medical Device Threat Modeling
• The SPDF Playbook for FDA-Ready Medical Devices
• FDA Cybersecurity Deficiency Response

Sources & primary references

• Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions. U.S. Food and Drug Administration (FDA)
• The Minimum Elements For a Software Bill of Materials (SBOM). National Institute of Standards and Technology (NIST)
• Vulnerability Exploitability eXchange (VEX) Overview. CISA (Cybersecurity & Infrastructure Security Agency)
• AAMI TIR57: Principles for medical device security, Risk management. AAMI (Association for the Advancement of Medical Instrumentation)

Talk to a regulatory cybersecurity team

If you are working through SBOM vulnerability management medical devices and want a second pair of eyes on your submission package, we ship cybersecurity deliverables for medical device manufacturers across 510(k), De Novo, PMA, and EU MDR pathways. Book a discovery session and we will walk your evidence with you.